CG Oncology (CGON) Total Liabilities (2023 - 2026)

CG Oncology's Total Liabilities history runs 4 years deep, the most recent figure standing at $43.5 million for Q1 2026.

• Quarterly Total Liabilities rose 85.64% year-over-year to $43.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.5 million (up 85.64% YoY) and the FY2025 annual result came in at $39.0 million, up 82.03% from the prior year.
• Total Liabilities was $43.5 million for Q1 2026 at CG Oncology, up from $39.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $43.5 million in Q1 2026 and bottomed at $10.2 million in Q1 2024.
• A 4-year average of $25.3 million and a median of $22.4 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities surged 47.61% — and 2025, when it jumped 169.22%.
• CG Oncology's Total Liabilities stood at $14.5 million in 2023, then jumped by 47.61% to $21.4 million in 2024, then surged by 82.03% to $39.0 million in 2025, then gained by 11.52% to $43.5 million in 2026.
• Business Quant data shows CGON's Total Liabilities at $43.5 million in Q1 2026, $39.0 million in Q4 2025, and $42.3 million in Q3 2025.